S&P 500   4,205.52 (+0.00%)
DOW   33,042.78 (-0.15%)
QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.41 (-3.77%)
BABA   78.67 (-2.84%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.08%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.53%)
AMC   4.63 (-0.22%)
PFE   37.01 (-1.57%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)
S&P 500   4,205.52 (+0.00%)
DOW   33,042.78 (-0.15%)
QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.41 (-3.77%)
BABA   78.67 (-2.84%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.08%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.53%)
AMC   4.63 (-0.22%)
PFE   37.01 (-1.57%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)
S&P 500   4,205.52 (+0.00%)
DOW   33,042.78 (-0.15%)
QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.41 (-3.77%)
BABA   78.67 (-2.84%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.08%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.53%)
AMC   4.63 (-0.22%)
PFE   37.01 (-1.57%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)
S&P 500   4,205.52 (+0.00%)
DOW   33,042.78 (-0.15%)
QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.41 (-3.77%)
BABA   78.67 (-2.84%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.08%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.53%)
AMC   4.63 (-0.22%)
PFE   37.01 (-1.57%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)
NYSE:BRCC

BRC (BRCC) Stock Forecast, Price & News

$5.63
+0.08 (+1.44%)
(As of 05:22 PM ET)
Compare
Today's Range
$5.53
$5.72
50-Day Range
$4.83
$5.67
52-Week Range
$4.79
$11.07
Volume
297,492 shs
Average Volume
538,775 shs
Market Capitalization
$1.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.75

BRC MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
73.2% Upside
$9.75 Price Target
Short Interest
Bearish
13.41% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.09) to $0.06 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.57 out of 5 stars

Consumer Staples Sector

126th out of 140 stocks

Beverages Industry

11th out of 11 stocks


BRCC stock logo

About BRC (NYSE:BRCC) Stock

BRC Inc., through its subsidiaries, purchases, roasts, and sells coffee, coffee accessories, and branded apparel. The company also produces media content; podcasts; and digital and print journals, as well as sells coffee brewing equipment, and outdoor and lifestyle gear. It supports active military, veterans, and first responders. The company offers its products through convenience, grocery, drug, and mass merchandise stores; outdoor, do it yourself, and lifestyle retailers; and company operated and franchised Black Rifle Coffee retail coffee shop locations, as well as through e-commerce. BRC Inc. was founded in 2014 and is based in Salt Lake City, Utah.

Receive BRCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BRC and its competitors with MarketBeat's FREE daily newsletter.

BRCC Stock News Headlines

BRC (NYSE:BRCC) Shares Up 7.6%
BRC (NYSE:BRCC) Stock Price Up 7.5%
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
BRC (NYSE:BRCC) Given New $5.50 Price Target at Citigroup
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
BRC (NYSE:BRCC) PT Lowered to $5.50
Expert Ratings for BRC
D.A. Davidson Keeps Their Buy Rating on BRC (BRCC)
BRC (BRCC) Gets a Buy from Telsey Advisory
BRC: Q1 Earnings Insights
BRC (BRCC) Set to Announce Quarterly Earnings on Thursday
Comparing BRC (BRCC) & The Competition
BRC (BRCC) & Its Rivals Head to Head Analysis
BRC (BRCC) and Its Peers Head-To-Head Review
Financial Comparison: BRC (BRCC) and Its Peers
See More Headlines
Receive BRCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BRC and its competitors with MarketBeat's FREE daily newsletter.

BRCC Company Calendar

Last Earnings
3/15/2023
Today
5/30/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Beverages
Sub-Industry
N/A
Fax
N/A
Employees
836
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.75
High Stock Price Forecast
$19.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+72.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-82,910,000.00
Pretax Margin
-30.80%

Debt

Sales & Book Value

Annual Sales
$301.31 million
Cash Flow
$0.89 per share
Book Value
$0.45 per share

Miscellaneous

Free Float
60,986,000
Market Cap
$1.20 billion
Optionable
Optionable
Beta
0.52

Key Executives

  • Mr. Roland C. Smith (Age 69)
    Exec. Chairman
  • Mr. Evan Hafer (Age 46)
    Founder & CEO
  • Mr. Thomas E. Davin (Age 65)
    Co-CEO & Director
  • Mr. Joseph E. Reece (Age 61)
    Chairman
  • Mr. Gregory J. Iverson (Age 48)
    Chief Financial Officer
  • Ms. Toby Johnson (Age 46)
    Chief Operating Officer
  • Mr. Chris Clark
    Chief Technology Officer
  • Mr. Andrew J. McCormick (Age 37)
    Gen. Counsel & Corp. Sec.
  • Mr. Martin Manning
    Chief HR Officer
  • Mr. Mat Best (Age 36)
    Chief Branding Officer













BRCC Stock - Frequently Asked Questions

Should I buy or sell BRC stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BRC in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BRCC shares.
View BRCC analyst ratings
or view top-rated stocks.

What is BRC's stock price forecast for 2023?

4 brokerages have issued 1-year price objectives for BRC's stock. Their BRCC share price forecasts range from $5.00 to $19.00. On average, they anticipate the company's share price to reach $9.75 in the next year. This suggests a possible upside of 72.6% from the stock's current price.
View analysts price targets for BRCC
or view top-rated stocks among Wall Street analysts.

How have BRCC shares performed in 2023?

BRC's stock was trading at $6.11 at the beginning of 2023. Since then, BRCC stock has decreased by 7.5% and is now trading at $5.65.
View the best growth stocks for 2023 here
.

When is BRC's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our BRCC earnings forecast
.

How were BRC's earnings last quarter?

BRC Inc. (NYSE:BRCC) issued its quarterly earnings results on Wednesday, March, 15th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by $0.04. The business earned $93.62 million during the quarter, compared to the consensus estimate of $92.59 million. BRC had a negative trailing twelve-month return on equity of 2.57% and a negative net margin of 7.77%.

What ETF holds BRC's stock ?

Fidelity MSCI Consumer Staples Index ETF holds 47,246 shares of BRCC stock, representing 0.02% of its portfolio.

What guidance has BRC issued on next quarter's earnings?

BRC issued an update on its FY 2023 earnings guidance on Friday, May, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $400.00 million-$440.00 million, compared to the consensus revenue estimate of $422.57 million.

What is BRC's stock symbol?

BRC trades on the New York Stock Exchange (NYSE) under the ticker symbol "BRCC."

Who are BRC's major shareholders?

BRC's stock is owned by a variety of institutional and retail investors. Top institutional investors include Cresset Asset Management LLC (0.95%), BlackRock Inc. (0.83%), Kim LLC (0.67%), Geode Capital Management LLC (0.27%), State Street Corp (0.26%) and Charles Schwab Investment Management Inc. (0.12%). Insiders that own company stock include Glenn W Welling and Gregory James Iverson.
View institutional ownership trends
.

How do I buy shares of BRC?

Shares of BRCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BRC's stock price today?

One share of BRCC stock can currently be purchased for approximately $5.65.

How much money does BRC make?

BRC (NYSE:BRCC) has a market capitalization of $1.20 billion and generates $301.31 million in revenue each year. The company earns $-82,910,000.00 in net income (profit) each year or ($0.47) on an earnings per share basis.

How many employees does BRC have?

The company employs 836 workers across the globe.

How can I contact BRC?

BRC's mailing address is 1250 S. CAPITAL OF TEXAS HIGHWAY BUILDING 2 SUITE 285, AUSTIN TX, 78746. The official website for the company is www.shearman.com. The company can be reached via phone at 801-874-1189 or via email at ir@blackriflecoffee.com.

This page (NYSE:BRCC) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -